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Abstract: We present a novel technique to predict the outcome of an RF ablation, including the vascular cooling effect. 
The main idea is to separate the problem into a patient independent part, which has to be performed only once for every 
applicator model and generator setting, and a patient dependent part, which can be performed very fast. The patient 
independent part fills a look-up table of the cooling effects of blood vessels, depending on the vessel radius and the 
distance of the RF applicator from the vessel, using a numerical simulation of the ablation process. The patient dependent 
part, on the other hand, only consists of a number of table look-up processes. The paper presents this main idea, along 
with the required steps for its implementation. First results of the computation and the related ex-vivo evaluation are 
presented and discussed. The paper concludes with future extensions and improvements of the approach.  
Keywords: Radiofrequency ablation, vascular cooling, fast prediction. 
1. INTRODUCTION 
  Cancer is currently a leading cause of death [1]. Over   
50  % of all patients suffering from colon cancer develop 
hepatic metastases [2]. Since surgical resection is often not 
applicable due to size, number, and location of the tumors, or 
due to the general constitution of the patient, minimally 
invasive therapies, such as radiofrequency (RF) ablation, 
have become very popular in the last years for both primary 
hepatic tumors and hepatic metastases [3]. 
  In RF ablation, a needle shaped probe is inserted into the 
tumor. The probe is then connected to an electric generator, 
which induces an electric current into the tissue. By Joule’s 
law, heat is produced, and above a certain critical 
temperature cell proteins denaturate, causing cell death. 
  Intervention planning is hampered by the fact that blood 
vessels in the vicinity of the RF probe can lead to a cooling 
effect and thus decrease the coagulation size [4]. Next to the 
area where the tissue is completely destroyed, there is a 
transition zone in which the tissue is still heated up, but the 
heat is not sufficient to cause cell death. There are some 
indications that possibly remaining tumor cells in this 
transition zone might become more aggressive and resistant 
towards further treatment than they would have been if no 
RF ablation had been performed: It is known that increased 
temperatures give rise to expression of heat shock proteins 
[5, 6], which may in turn later-on protect the cells against 
heat-induced apoptosis [7]. Also, the transition zone 
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develops an increased activity of matrix metalloproteinase 
[8], which is known to be connected to an increased risk of 
tumor recurrence in colorectal cancer [9]. Although the 
clinical relevance of these correlations is yet unknown and 
there are also a number of indications for the converse point 
of view (see also the overview paper of Mulier et al. [10]), 
we argue that incomplete tumor ablation should be avoided 
whenever possible. 
  From the slices of a CT scan, it is typically even hard to 
tell how distant a tumor is located from a large blood vessel, 
not to mention the cooling effect of this blood vessel on the 
necrosis. This causes a need for computer assisted planning 
tools and simulations of the ablation, including the vascular 
cooling effect. Such simulations are developed by various 
authors. The way in which vascular cooling is taken into 
account varies considerably: Simple models use heuristics to 
quantify the cooling effects [11] or do not consider patient 
individual vascular systems at all [12]. More advanced 
approaches model individual vessels by a fixed heat sink [13, 
14], and some authors even take blood flow together with 
heat exchange between vessel and tissue into account [15-
17]. For a comprehensive review, see the overview article by 
Berjano [18]. However, the more precise cooling is 
considered, the slower the computations are, and, in fact, all 
models—except those that are based on heuristics—are far 
too slow to be usable in clinical practice. 
  In the current publication, we present a novel approach to 
overcome this dilemma. The idea is to separate the 
computationally intensive part of the simulation from the 
patient dependent part as much as possible. Computations Fast Estimation of the Vascular Cooling in RFA Based  The Open Biomedical Engineering Journal, 2010, Volume 4    17 
that are not dependent on the individual anatomy of the 
patient can be performed in advance and, if necessary, on 
high-performance computers. For a given RF applicator and 
generator type, our idea is to precompute the cooling effect 
of blood vessels, depending on the vessel radius and its 
distance to the applicator, and to store these results in a table. 
Once the table has been generated, the cooling effects for 
any individual case can be estimated and visualized in real 
time. Our method points out tumor regions that would be 
underablated due to vascular cooling and can thus help the 
attending physician to choose a suitable applicator placement 
or to decide whether additional steps like a Pringle 
manoeuvre or chemoembolization should be applied. 
2. MATERIALS AND METHODS 
  In Sect. 2.1, we describe the basic concept of the method, 
consisting of a quantitative description of necrosis zones in 
the presence of a vessel as well as an extension model for the 
case of a complete vascular tree. Section 2.2 briefly 
addresses the creation of an adaptive look-up table. The 
mathematical model of RF ablation that we use in this work 
is presented in Sect. 2.3. along with its numerical 
approximation in Sect. 2.4.. The setup for our example 
computations and a first ex-vivo evaluation are described in 
Sect. 2.5. 
2.1. Quantitative Description of Necrosis 
2.1.1. Single Vessel Model 
  Let us first simplify the general setting by considering the 
situation of one straight blood vessel of infinite length, 
oriented parallel to the RF applicator. The cooling effect of 
this vessel—for a fixed applicator type and generator 
setting—is assumed to depend on the radius rves of the vessel 
and on the distance  dap  of the applicator from the vessel. 
(Other influence factors, such as the vessel type, will be 
respected in our forthcoming research.) We quantify the 
cooling effect by stating the size rnec  of the necrosis, 
measured from the applicator’s center, in all directions 
orthogonal to the applicator axis. 
  Using a forward simulation (cf. Sect. 2.3), we establish a 
connection between the vessel radius rves , the distance dap  
of the applicator from the vessel, and the resulting necrosis 
size  rnec , which is a function of the direction, expressed as 
the angle nec  between the direction under consideration and 
the direction in which the vessel center is located. For 
reasons of symmetry, it suffices to consider nec [0,]. We 
formally denote this relation as a function  
 : [0,)[0,)[0,][0,)  
       (rves,dap,nec)   rnec  
see also Fig. (1). For a precise definition we refer the reader 
to Sect. 2.3. 
  In the case of an encasement of the vessel, we measure 
the distance to the outer-most boundary of the necrosis area. 
This measurement ignores the fact that there will be a thin 
layer of unaffected tissue around the vessel. To compensate 
for this, we additionally measure the thickness tube  of this 
tube and hence employ another function  
 : [0,)[0,)[0,] (rves,dap) tube  
see Fig. (2), where we approximate the tube by a circular 
cylinder. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Schematic sketch of the situation in the case of an 
encasement. 
 
2.1.2. Full Model 
  Now, let the complete vascular system be given as a set 
of straight vessel segments with end points  ai,bi R
3  and 
radii  ri > 0  where i=1,…,N (such a charaterization can be 
obtained using the methods presented earlier [19, 20]), and 
let  a
*  and b
*  denote the applicator’s active zone’s end 
points and r
* the applicator’s radius (cf. Fig. 3). We make 
the simplification that the cooling effect of the blood vessels 
is additive in the sense that the necrosis achieved in the 
presence of two blood vessels A and B is given by the 
intersection of those achieved in the presence of only vessel 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic sketch of the quantities that are related by the 
function . 
dap rves
rnec
αnec vessel
applicator
necrosis
rnec
θtube
vessel
applicator
necrosis18    The Open Biomedical Engineering Journal, 2010, Volume 4  Kröger et al. 
A and only vessel B – see Fig. (4). For clinically relevant 
settings, this can be assumed to be a sufficiently good 
approximation. 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Location of the points  ai  and bi  (for some value of i) as 
well as a
*  and b
* . 
 
 
 
 
 
 
Fig. (4). Assumption of additive cooling: The necrosis achieved in 
the presence of two blood vessels A and B is in clinically relevant 
settings sufficiently well aproximated by the intersection of those 
achieved in the presence of only vessel A and only vessel B. 
 
  In the following, we denote by [a,b] the straight line from 
a R
3  to b R
3  and by abc the angle between the lines 
ab  and bc. Additionally, by  dr,s(a,b)  we denote the 
distance of a ball of radius r around a from a ball of radius s 
around b, i. e.  
dr,s(a,b) = a  b  r  s  
 Let   R
3  be a given point in the tissue, and we want to 
decide whether the tissue at this point will be destroyed by 
the ablation or not. For each choice of a point  x [a
*,b
*] on 
the applicator’s active zone and a point  y [ai,bi] in the i’th 
vessel segment, we consider the plane containing , x, and y 
and apply the considerations described in Sect. 2.1.1 in this 
plane. 
  The transformation to that plane is not actually computed 
since the distances of the points , x, and y from each other 
together with the angle in x suffice to obtain the required 
information.  is destroyed if it is contained in the necrosis 
described by the function , but not in the tube described by 
the function ; that is, if 
  x   (r,d
r,r
*(y,x),yx)  and  
  y   (r,d
r,r
*(y,x))  
  We therefore define  
C
y,r,r
*
(1) (x) = { R
3 :   x  (r,d
r,r
*(y,x),yx)}       (1a) 
C
y,r,r
*
(2) (x) = { R
3 :   y  (r,d
r,r
*(y,x))}        (1b) 
so that the set C
y,r,r
*
(1) (x)C
y,r,r
*
(2) (x) describes the necrosis for 
fixed x and y. 
 Now,  let  y vary over the vascular tree. This corresponds 
to taking several vascular segements into account and hence 
reduces the necrosis to the intersection of the corresponding 
sets. Finally, let x vary along the active zone’s centerline. 
Since longer electrodes generate longer coagulation zones, 
we take the union of all the respective necrosis sets. The 
final formula for the necrosis hence reads  
C
 
= C
y,ri,r
*
(1) (x)C
y,ri,r
*
(2) (x) ()
y[ai ,bi ]

i=1
N

x[a*,b*]
        (1c) 
  For the case where all vessel segments are too distant 
from the applicator to have any effect, this results in the 
union of balls with equal radius around all the points on the 
active zone, see Fig. (5). 
 
 
 
 
 
Fig. (5). In the absence of near-by vessels, the estimated necrosis 
consists of the union of balls around all the points on the electrode. 
 
2.2. Adaptive Creation of Look-Up Table 
  Let us assume that the functions  and  (cf. Sect. 2.1) 
are known in the sense that for given  rves ,  dap  and nec , the 
values  (rves,dap,nec) and (rves,dap)  can be computed, but 
this computation is too slow for clinical application. The idea 
is to approximate  and  by some functions 
~
 and 
~
, 
respectively, with the following properties:  
1.  The construction of 
~
 and 
~
 (for a given tolerance) 
requires preferably few evaluations of  and .  
2. Once  
~
 and 
~
 have been computed, they can be 
evaluated very fast.  
  An easy possiblity consists of the evaluation of the 
functions on a uniform grid and storage of the function 
values in an array, together with a piecewise multilinear 
interpolation (that is, trilinear for  and bilinear for ). 
However, it can be expected that this will result in many 
unnecessary evaluations since the functions might be 
approximately multilinear in some regions and more 
essentially non-multilinear in others. 
  For that reason, we use an adaptive hierarchic grid 
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consisting of a hierachical ansatz space of piecewise 
multilinear functions. This produces a fine grid (i. e. small 
pieces on which 
~
  and  
~
 are multilinear) in regions where 
this is necessary only. However, in the nec  direction, we 
use a full grid, since all values can be obtained from the 
same simulation result here. 
  Analogously to (1), we define approximations   C , 
 
 C
y,r,r
*
(1) , 
and 
 
 C
y,r,r
*
(2) . We emphasize that no special properties of any 
particular forward simulation model are utilized here. 
2.3. A Mathematical Model of RF Ablation 
  In this section, we briefly describe the forward simulation 
model that we used to produce the results shown in Sect. 3,  
i. e. the employed functions  and  (in the notation of Sect. 
2.1). 
  As mentioned briefly in the introduction, a broad variety 
of simulation models for RF ablation exist, and they differ 
not only in the way in which they consider vascular cooling. 
They range from simple geometric models that use ellipsoids 
to describe the necrosis [11] over time dependent PDE 
models with constant coefficients [13, 16] to complex 
models that take cell water evaporation and temperature 
dependent material parameters into account [14, 15, 17]. 
Some authors exploit rotational symmetry around the 
applicator axis [12], which is of course impossible if the aim 
is to consider patient individual vascular systems. 
  Since the precomputation typically involves several 
hundred of calls of the forward simulation, we currently use 
a simplified forward simulation model here. It assumes 
constant material parameters and is based on a steady state 
solution. Since also the electric conductivity is assumed to be 
equal in the parenchyma and the blood vessel, the 
computation of the electric power density is independent of 
the location and the geometry of the vessel. Hence, for a 
given applicator type and generator setting, the potential 
equation (see (2) below) has to be solved only once, whereas 
the steady state bio-heat equation (see (4) below) has to be 
solved for varying blood vessel configurations. We further 
simplify our model by assuming the applicator to be placed 
in a direction parallel to the blood vessel and then computing 
the steady state bio-heat transfer equation in two space 
dimensions only. Note that for reasons that will become clear 
below, the potential and power computation must, in 
contrast, be computed in three space dimensions. 
  More specific, we consider a cuboid shaped 
compuational domain R
3 that is chosen large enough 
such that any influences from outside can be neglected. 
Without loss of generality, we assume the centerlines of both 
the applicator and the blood vessel to be aligned in  x3  
direction and have an  x2  coordinate of 0, cf. Fig. (6). The 
center of the applicator’s active zone is placed in the origin; 
the  x1 position of the blood vessel is chosen to be negative 
and such that the distance between blood vessel and 
applicator matches the prescribed value dap . The open 
subdomains of  occupied by blood vessel, electrodes, and 
applicator are denoted by ves,  ± , and pr . Here, one of 
the electrodes is arbitrarily chosen to be +  and the other 
 , both of which are subsets of pr ; in the case of a 
monopolar probe, only +  is used. Further, we let  
out =     ves = ves  
±  = ± \pr    iso = (pr )\±  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Schematic sketch of the geometric setup. 
 
  Since the electric potential (x) can be considered as 
quasistatic [12], we can model it as the solution of the 
elliptic boundary value problem [14]  
(x)      = 0  in \pr            (2a) 
(x)             =± 1V  on ±            (2b) 
n(x)(x) = 0  on iso             (2c) 
n(x)(x) =
n(x)(s  x)
s  x
2 (x) on out          (2d) 
 Here,  >0 is the electric conductivity, s is the center of 
the applicator’s active zone, and n(x) is the outward normal 
vector. It is a well-known fact that this problem has a unique 
weak solution  H
1(\±) where  H
1 = H
1,2  denotes the 
Sobolev space of functions whose weak first derivatives are 
square integrable [22]. 
  The electric power density p is now given by [14]  
x1
x2
x3
 pr
 −
 +
 ves
dap rves
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p(x) =
peff
ptotal
 (x)
2   where  
ptotal =
\pr   (x)
2 dx   (normalization factor)  
peff =
4psetupRtisRI
(Rtis + RI)
2    (effective power)  
Rtis =
U
2
ptotal
    (tissue impedance) 
U =
     1V monopolar   (difference of the values  
 
and the remaining quantities are properties and settings of 
the electric generator, namely its inner resistance  RI  and the 
setup power  psetup . (These formulae arise from an equivalent 
circuit that models the generator by a constant voltage source 
and an inner resistance. Even though we use a steady state 
model, it is important to capture this power scaling since it is 
a fact that the effective power is generally lower than the 
setup power, cf. Sects. 2.5.2 and 3.2). 
 It is well-known [23] that  p L
1( \ pr) 
H
1( \ pr), and if we extend p to  by setting 
p|pr = 0 , we have  p L
1() H
1(). 
  Performing these computations in two (rather than in 
three) space dimensions would result in a mismatch of units: 
ptotal  would be an integral over a two-dimensional domain 
only, hence have a unit that differs by a factor of a meter 
from the correct unit. In consequence, this would  Rtis  cause 
to have a wrong unit as well, and finally the equation for 
peff  would not be well-defined any more, since two 
quantities with different units would be added in the 
denominator. The physics of electric fields and electric 
potentials behaves differently in two dimensions than in 
three. 
  The temperature equation, on the other hand, can easily 
be performed two-dimensional. To do this, we let    denote 
the intersection of  and the  x1- x2  plane as a subset of  R
2 , 
i.  e.   
  = {(x1,x2):(x1,x2,0)} (see again Fig. 6) and 
analogously for ves,  pr , and  out . Further, we let 
  p H
1(  )  be given by   p =P(p) where  
P :H
1()    H
1()             (3) 
is a suitable projection to be specified below. The remaining 
modelling is completely performed in two space dimensions, 
but for simplicity of notation, we will omit the    symbol 
from now on. 
  The temperature distribution T(x) is modelled by the two-
dimensional steady state bio-heat equation [14, 24, 25] 
  
T(x)     = p(x)+(Tbody T(x)) in \( ves pr) (4a) 
n(x)T(x) = 0  on out              (4b) 
T(x)             = Tbody  on ves pr           (4c) 
where >0 is the thermal conductivity, Tbody  is the native 
body temperature, and  quantifies the cooling due to small 
vessels, which are assumed to pervade the complete tissue. 
This is again an elliptic boundary value problem with unique 
weak solution T H
1(). 
 Once  T is known, we let coag  denote the set of 
coagulated tissue,  
coag = {x :T(x)Tcrit}  
(where  Tcrit  is a critical temperature above which the tissue 
is assumed to be destroyed). 
  Finally, we define the necrosis size  rnec  in a direction 
nec  and the thickness tube  of the uneffected tissue tube 
according to the size and shape of coag  as described in Sect. 
2.1.1. Since, however, a point evaluation of a function in  H
1 
is in general not defined, the set coag  is only defined up to 
sets of measure zero, so that the precise definition of rnec  and 
tube  is given by  
rnec = sup{r  0:>0 B(renec)coag > 0}  
tube = sup{r  0:Br+rves(xves)coag = 0}  
where  e = (cos ,s i n   ) and  xves  is the position of the 
vessel’s centerline in  (i. e.  xves = (rves dap,0)),  B(x) 
denotes a ball of radius  around x, and    denotes the 
Lebesgue measure of a set. 
Now that the description of our functions  and  is 
finished, we would like to add some remarks: 
1.    The described forward simulation model provides 
only a rough approximation of the ablation outcome. 
This is, however, not a substantial drawback since 
any other model can be plugged in easily, thus any 
level of precision can be achieved without slowing 
down the patient individual estimation.  
2.  It is well-known that a chemical process like the 
denaturation of liver cells is not only a function of 
temperature, but in fact also depends on the duration 
for which a given temperature is applied. Hence, a 
better model for the set coag  would be to apply the 
Arrhenius formalism [12, 14, 26]. However, a steady-
state solution does obviously not supply the required 
time information.  
3.  A possible choice of the projection P (cf. (8)) is  
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(P  p)(x1,x2)
=


 p(x1,x2,x3) (x3)dx3


  (x3)dx3
 
where 2 is the length of the applicator’s active zone 
and    C
(R) is a non-negative function with 
compact support in [,] and the property that 
    |[+,]1. It is straight forward to prove that  P   
is well-defined, but the norm does not remain 
bounded for 0. In other words,  
(P 0p)(x1,x2)
 
=
1
2 

 p(x1,x2,x3)dx3  
does apparently not provide a mapping 
 H
1() H
1(  ), and although P   does provide 
such a mapping for any >0, the result might 
theoretically depend essentially on the (arbitrary) 
choice of . In the view of remark number 1, we argue 
that for a full (three-dimensional) forward model, no 
such mapping will be required any more anyway. 
Also, the numerical approximation  ph  of the power 
density  p (see Sect. 2.4 below) is an element of 
L
(), so that P 0(ph) is well-defined, and so is even 
P *(ph), where  P * is defined by  
  (P *p)(x1,x2) = esssupx3 [,]p(x1,x2,x3) 
  In our numerical examples, we are using the 
projection  P *.  
2.4. Numerical Approximation Using Finite Elements 
  Both elliptic boundary value problems, (2) and (4), are 
solved with standard finite element approaches [22]: We 
cover the computational domain  (that is, = for the 
electric potential or =   for the temperature) with a 
uniform Cartesian grid with grid parameter h>0. Let Vh  be 
the space of all continuous functions on  that are 
piecewise trilinear (bilinear for (4)). Let ±,h ,  pr,h , and 
ves,h  denote the union of all grid cells that have non-empty 
intersection with ± ,  pr , or ves, respectively, and let 
out,h ,  ves,h ,  ±,h , and  iso,h  be defined as the respective 
boundary sections. Further, for any topological space X and 
any set F of functions XR, any subset M
X, and any 
number cR, we use the notation  
F
M=c = {f F :F |M  c} 
i.  e.  F
M=c denotes the set of functions in F that take the 
constant value c everywhere on M. 
  With this notation, our numerical solution h  of the 
potential equation (2) is given by  
\pr,h  h(x)vh(x)dx =
out,h  
n(x)(s x)
s x
2 h(x)vh(x)dA(x) 
for all  vh Vh
±,h=0  and the additional condition  
h  Vh
+,h=1,,h=1 
  This results in a system of linear equations for the nodal 
values of 
h that offers a unique solution. The temperature 
equation (4) is discretized analogously. 
2.5. Experimental Setup 
2.5.1. Computational Experiments 
  We performed the patient independent precomputation as 
described in this paper for a virtual RF applicator that was 
modelled according to the properties of a CelonProSurge 
150-T30™ applicator (Celon AG, Teltow, Germany; cf. 
Sect. 2.5.2 below). Further, we assumed an electric generator 
with an inner resistance of 80 , set up to a power of 30 W. 
In the two-dimensional computation of the temperature 
distribution, we used a computational domain    with an 
extent of 60	60 mm, covered with a grid of width 0.1 mm. 
For the three-dimensional computation of the electric 
potential, we used a domain  of extent 38	38	50 mm with 
a grid width of 0.1 mm in  x1 and x2  directions, but a width 
of 1  mm in  x3  direction. The tissue was assumed to 
denaturate at a temperature of Tcrit = 50
C . The material 
parameters , , and  were chosen as follows [14]:  
 =0.21 
S/m    =0.437 
W/Km 
and  
   =0bloodcblood   where  
0   = 0.01765s
1   (relative blood flow rate) 
blood   =1059 kg /m
3  (blood density)  
cblood   = 3850 J /gK   (blood heat capacity) 
2.5.2. Ex-Vivo Experiments 
  A first clinical ex-vivo evaluation of our model has been 
performed. The clinically relevant part of the evaluation is 
published separately [27]; we focus here on the aspects that 
are essential in connection with the current publication. 
  Pieces of fresh porcine livers were ablated using a 
CelonProSurge 150-T30™ applicator (bipolar, active zone 
length 30 mm, isolator length 3 mm, radius 0.9  mm). The 
power unit was set up to  psetup = 30W, but note that due to 
the varying tissue impedance, the effective power was 
generally below that value. The ablation was performed until 
a total energy amount of 15 kJ had been induced (where the 
required duration varied, see Sect. 3.2 below for details). A 
glass tube, arranged parallel to the applicator and connected 
to a pump with an adjustable flow rate of saline, has been 
used to simulate a blood vessel. The experiments were 22    The Open Biomedical Engineering Journal, 2010, Volume 4  Kröger et al. 
performed at room temperature (25˚C). A number of 
experiments has been performed that varied in  
• the  distance  dap  of the glass tube from the applicator 
(5 mm or 10 mm),  
• the  radius  rves  of the glass tube (outer radius between 
2.5 mm and 5 mm), and  
•  the flow rate in the glass tube (between 8.3 
cm/s and 
330 
cm/s, which includes the range that has been 
measured in hepatic blood vessels [15, p. 79], [28, p. 
62]).  
  After each experiment, the liver was cut perpendicular at 
the center of the applicator. A photograph was taken and 
imported into a software tool. The lesion border, applicator 
center, and glass tube location were marked manually with 
that software tool. 
3. RESULTS 
3.1. Computational Results 
  The computations described in Sect. 2.5.1 generated a 
sparse look-up table containing 526 nodes in the (r
ves,d
ap) 
plane, where 65 values in the direction 
nec were stored. The 
computation required less than 2 
1
2 hours on a four-years-old 
standard desktop computer, where about 20 minutes of this 
time were required to compute the electric potential  and 
power density p (cf. Sect. 2.3). 
 Fig.  (7) shows a reconstruction of the necrosis area from 
the data stored in the look-up table for various values of r
ves 
and d
ap. We did not consider vessels with a radius below 1 
mm (diameter below 2  mm) since these will usually be 
destroyed by blood clots [29]. As can be seen in the figure, 
encasement can happen (although only rarely), which 
justifies the additional consideration of a tube of unaffected 
tissue around the vessel. On the other hand, in cases where 
encasement happens, the tube is very thin (fractions of a 
millimeter). This is confirmed by Fig. (8), which shows a 
plot of the tube thicknesses (values of ) as functions of d
ap 
for various values of r
ves: The tube thickness remains below 
a clinically significant value for settings in which 
encasement is imaginable to occur; note that encasement can 
in particular not occur for dap > 9mm  since the maximally 
obtained coagulation radius is about 10 mm. 
 
 
 
 
 
 
 
 
Fig. (8). Plots of the tube thickness tube  as a function of the 
distance  dap  for fixed values of the vessel radius  rves , that is, the 
graph of the function  (rves,) . Shown plots are for  rves =1, 2.5, 
4, 5 (bottom to top, millimeters). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Plot of the necrosis (solid line) for selected values of the vessel radius rves  and the applicator distance  dap , as reconstructed from the 
look-up table, i. e. from the function    . For reasons of symmetry, we only show the top half plane. For clarity, the corresponding vessel 
(gray) is also shown. Given quantities are in millimeters. An encasement occured in the top left case—the (very small) tube of unaffected 
tissue (thickness tube = 0.05mm ) is not shown. Framed plots correspond to the ex-vivo experiments shown in Figs. (10-12). 
2 3 4 5 6 7 8 9 10 11 12 13 14 15
0
1
2
3
4
5
dap [mm]
θtube [mm]
rves = 1.0
dap = 2.0
5 10 5 10
rves = 1.0
dap = 5.0
5 10 5 10
rves = 1.0
dap = 8.0
5 10 5 10
rves = 1.0
dap = 10.0
5 10 5 10
rves = 1.7
dap = 2.0
5 10 5 10
rves = 1.7
dap = 5.0
5 10 5 10
rves = 1.7
dap = 8.0
5 10 5 10
rves = 1.7
dap = 10.0
5 10 5 10
rves = 2.5
dap = 2.0
5 10 5 10
rves = 2.5
dap = 5.0
5 10 5 10
rves = 2.5
dap = 8.0
5 10 5 10
rves = 2.5
dap = 10.0
5 10 5 10
rves = 4.0
dap = 2.0
5 10 5 10
rves = 4.0
dap = 5.0
5 10 5 10
rves = 4.0
dap = 8.0
5 10 5 10
rves = 4.0
dap = 10.0
5 10 5 10
rves = 5.0
dap = 2.0
5 10 5 10
rves = 5.0
dap = 5.0
5 10 5 10
rves = 5.0
dap = 8.0
5 10 5 10
rves = 5.0
dap = 10.0
5 10 5 10Fast Estimation of the Vascular Cooling in RFA Based  The Open Biomedical Engineering Journal, 2010, Volume 4    23 
  Since considering this tube does not slow down the 
computation essentially (neither when creating the tables nor 
when applying the result to a patient specific data set), we 
currently decide to retain it. 
  An interactive software tool, based on the MeVisLab 
platform (www.mevislab.de), has been developed that is 
meant to assist the physician in the planning of the 
intervention. It allows for placement and rearrangement of 
one or several RF applicators and uses colors and arrows to 
point out underablated tumor regions. See Fig. (9) for an 
example obtained from a clinical real CT data set, from 
which the tumors and vessel trees were segmented and 
preprocessed with methods presented earlier [19, 20]. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (9). Screenshot of the interactive visualization tool, displaying 
the vessels (red), the applicator (gray and light red), and the original 
CT image (gray). A tumor is displayed as well, using three different 
colors: transparent gray for parts that will be destroyed, brown for 
parts that will possibly remain unaffected due to a too large distance 
from the applicator, and green for parts that will possibly remain 
unaffected due to the influence of blood vessels. A blue arrow 
points to the latter to catch the observer’s eye. 
 
  In the visualization, every point  on the tumor surface 
has to be checked for its containedness in C, which involves 
a double loop over the points of the vessel skeleton and the 
electrode axis. We speed up the computation by instead of 
the outer loop, computing the projection  x
* = p
[a
*,b
*]() of  
onto the electrode axis and replacing the check for C with 
the check  
  
 
 C
y,ri,r
*
(1) (x
*)C
y,ri,r
*
(2) (x
*) ()
y[ai ,bi ]

i=1
N
  
for this x
*, which, although it potentially underestimates the 
necrosis, did apparently not influence the result in the 
examined cases. 
3.2. Ex-Vivo Results 
  The mean duration of the experiments described in Sect. 
2.5.2 was 985 s with a standard deviation of 141 s (n=361). 
Three example results are shown in Figs. (10-12); note again 
that the clinically relevant part of the ex-vivo study is 
published separately [27]. 
  It turned out that between intervention and measurement, 
a deformation of the tissue and, in particular, a shrinkage of 
the necrosis took place, which made a quantitative 
comparison challanging (see figures). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (10). Result of an ex-vivo experiment with rves = 2.5mm and 
dap = 5mm. The red line is the manually drawn contour of the 
coagulation. The maximal radius of this contour, measured from 
the applicator’s center, is determined automatically, and a green 
circle with this radius is drawn. The cyan circle is the contour of the 
glass tube (also located manually). The amber lines specify a user-
defined angle that is irrelevant for the results presented here. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (11). Result of an ex-vivo experiment with rves = 2.5mm and 
dap =10mm . 24    The Open Biomedical Engineering Journal, 2010, Volume 4  Kröger et al. 
  Nevertheless, the evaluation can be used to check the 
computation results for plausibility. As can be seen from the 
images, the shape of the necrosis area apparently coincides 
with the computed results (cf. framed plots in Fig. 7), and so 
do the total size and, in particular, the distance between the 
vessel and the necrosis (tube ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (12). Result of an ex-vivo experiment with  rves = 5mm  and 
dap = 5mm. 
 
  Additionally, the results give rise to the conclusion that 
the blood flow rate has essentially no influence on the 
ablation result [27]. This implies that the blood is not heated 
up considerably, i. e. the Dirichlet boundary condition for the 
temperature (4c) is justified. Other authors consider the so-
called thermal equilibration length, that is the length of a 
blood vessel within which the blood is heated up such that 
the temperature difference to the surrounding tissue is 
reduced by a factor of exp(1). According to Creeze and 
Lagendijk [30], the thermal equilibration length for vessels 
of the size we are concerned about is essentially above the 
length scale which the heat of an RF applicator affects, 
which confirms our observation. 
  Another point is that the ex-vivo results do not show a 
significant dependence on the vessel radius [27]. The 
computational results clearly indicate such a dependence. 
However, this is not a contradiction, since this dependence 
mainly appears if  rves  and / or  dap  are chosen outside the 
range covered by the ex-vivo experiments (that is, 
rves < 2.5mm  or  dap < 5mm ), see again Fig. (7). 
 Additional  ex-vivo experiments were performed to verify 
that the glass did not influence the necrosis: We compared 
experiments with disabled pump to those without any glass 
tube, not obtaining visual differences [27]. 
4. DISCUSSION 
  We presented a concept for a fast estimation of the 
cooling effects induced by the vascular systems in hepatic 
RF ablation. The idea is based on patient-independent 
precomputations, the results of which are stored in a look-up 
table. Currently, the look-up table establishes a relationship 
between the radius of a vessel, the distance of an RF 
applicator from the vessel, and the cooling effect due to this 
vessel. The cooling effect is expressed as a direction 
dependent size of the necrosis, together with the distance 
from the vessel in which tissue remains unaffected. 
  The results of our computation can be visualized using a 
tool that allows to place and move applicators interactively 
and is meant to assist the physician in the intervention 
planning step. First ex-vivo experiments confirmed some of 
the computational results. 
  We would like to emphasize that our visualizations are 
not meant to replace a thorough intervention planning, nor 
are they meant to claim that in certain situations RF ablation 
cannot be successful. It is of course up to the physician’s 
choice to perform additional steps like a Pringle manoeuvre 
or chemoembolization to avoid the cooling effect. 
In our future work, we plan a number of extensions to our 
model, including the following:  
•  We will replace the currently used, partially two-
dimensional forward simulation model (Sect. 2.3) 
with a fully three-dimensional, time-dependent model 
that also takes state dependent material paramters into 
account.  
•  We will examine whether the orientation of the 
applicator (in relation to the blood vessel) has an 
essential influence on the result and include this 
parameter into the look-up table, if necessary. This 
will introduce additional dimensions in the look-up 
table, hence requiring essentially more 
precomputations.  
  Other subjects of future work are a thorough evaluation, 
including a verification of the assumption of additive cooling 
(cf. Sect. 2.1), as well as the creation of look-up tables for a 
large number of clinically employed applicator and generator 
types and settings. The validity of our modelling of the blood 
vessels (constant temperature, same electric conductivity as 
in the parenchyma) will also be examined. 
  In view of a more realistic evaluation, it would be useful 
to employ a setup similar to that described by Lubienski   
et al. [31]. 
  As has been published earlier [32, 33], the cooling effect 
of different hepatic vascular systems (that is in particular, the 
portal venous (PV) versus the hepatic venous (HV) tree) 
result in considerably different necrosis shapes, see Fig. (13). 
However, to our knowledge, no forward simulation model 
for the incorporation of this effect has been proposed by 
now. Once such a model has been developed, we will 
incorporate it into our concept. Note that this is straight 
forward by just preparing independent look-up tables for 
these two systems (roughly doubling the number of 
precomputations). 
  Finally, we would like to remark that our proposed 
method strongly relies on a precise vessel and tumor 
segmentation result. The radius information supplied by the 
currently employed segmentation algorithm [19, 20] is, Fast Estimation of the Vascular Cooling in RFA Based  The Open Biomedical Engineering Journal, 2010, Volume 4    25 
however, not accurate enough for this purpose [34]. Note 
that even although the vessel radius is less decisive for the 
cooling effect (cf. Sect. 3.2), an incorrect vessel radius will 
(supposed that the vessel centerline has been determined 
correctly) also essentially distort the information about the 
distance of both applicator and tumor from the vessel. Once 
better segmentation procedures have been developed, they 
can directly be used by our model—recomputation of the 
look-up tables will not be necessary. 
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